Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A Randomized, Controlled Phase 3 Study of Cabozantinib (XL184) in Combination with Atezolizumab versus Sorafenib in Subjects with Advanced H… Ended

2024-516479-34-00 Hepatocellular carcinoma 5 2019-05-17
A Trial for relapsed and relapsed/refractory multiple myeloma patients Ended

2023-506733-30-00 Multiple Myeloma relapsed and/or refractory 4 2019-05-16
A randomized trial that compares Carfilzomib - Lenalidomide - Dexamethasone (KRd) versus Lenalidomide - Dexamethasone (Rd) in new diagnosed … Ended

2024-513396-41-00 PATIENTS WITH NEW DIAGNOSIS MULTIPLE MYELOMA WITH AGE > 5 2019-05-15
Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer Ended

2024-512165-13-00 Localised unresectable adenocarcinoma or squamous cell 4 2019-05-13
Phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer considering two different… Ended

2024-514706-31-01 Epithelial ovarian cancer, Fallopian tube ovarian cance 5 2019-05-02
GEN1046 Safety Trial in Patients With Malignant Solid Tumors Ended

2023-509059-15-00 Malignant solid tumors: endometrial carcinoma (EC), uro 7 2019-04-30
Therapy with ibrutinib for patients with Chronic lymphocytic leukemia with subclonal TP53 aberrations Ended

2024-514823-41-00 Chronic Lymphocytic Leukemia (CLL) 4 2019-04-29
Treatment of High-risk Non-muscle Invasive Bladder Cancer With IMUNO BGC Moreau RJ as Prophylaxis Ended

2024-519288-17-00 High-risk Non-muscle Invasive Bladder Cancer 4 2019-04-26
Study of durvalumab or placebo administered with radiation therapy for patients with early stage non-small cell lung cancer Study of osime… Ended

2024-512667-31-00 Main cohort: Patients with unresected Stage I/II, lymph 5 2019-04-23
A multicenter, open label, randomized phase II study comparing daratumumab combined with bortezomib-cyclophosphamide-dexamethasone (Dara-VCd… Ended

2024-511781-37-00 YOUNG PATIENTS AFFECTED BY MULTIPLE MYELOMA (MM) TO THE 4 2019-04-16
TALAPRO 2: A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY OF TALAZOPARIB WITH ENZALUTAMIDE IN METASTATIC CASTRATION RESISTANT… Ended

2023-509087-20-00 Metastatic Castration-resistant Prostate Cancer 5 2019-04-16
Image‐guided de‐escalation of neoadjuvant chemotherapy in HER2‐positive breast cancer: the TRAIN‐3 study Ended

2024-516205-23-00 Breast cancer 4 2019-04-09
Study of efficacy and safety of tisagenlecleucel in HR B-ALL EOC MRD positive patients Ended

2023-508081-15-00 High-risk B-cell acute lymphoblastic leukemia 4 2019-04-04
Phase 2, Open-Label Safety and Efficacy Study of Telisotuzumab Vedotin (ABBV-399) in Subjects with Previously Treated c-Met+ Non-Small Cell … Ended

2023-507902-15-00 Non-Small Cell Lung Cancer 4 2019-03-26
This study is being done to test the effectiveness and safety of an investigational drug called acalabrutinib (ACP-196) when taken with alre… Ended

2023-509349-11-00 Previously untreated Chronic Lymphocytic Leukemia Witho 5 2019-03-22
Prostate cancer with OligometaSTatic relapse: Combining stereotactic Ablative Radiotherapy and Durvalumab (MEDI4736), a randomized phase II … Ended

2024-513207-13-00 oligometastatic hormone sensitive prostate cancer 4 2019-03-21
A Study of Zolbetuximab (IMAB362) in Adults with Pancreatic Cancer Ended

2024-510985-17-00 First Line Treatment in Subjects with Claudin 18.2 (CLD 4 2019-03-14
A clinical gene therapy study with hematopoietic stem cells for the treatment of patients suffering from a malignant neoplasm of the central… Ended

2023-510299-29-00 Glioblastoma multiforme 7 2019-03-13
A global study of midostaurin in combination with chemotherapy to evaluate safety, efficacy, and pharmacokinetics in newly diagnosed pediatr… Ended

2023-509834-20-00 untreated FLT3-mutated Acute Myeloid Leukemia 4 2019-03-13
Study of TSR-022, a Monoclonal Antibody, in Patients with Advanced Solid Tumors Ended

2023-507564-39-00 Patients with Advanced Solid Tumors 1 2019-03-11
A Phase 3 Study of Niraparib in Combination with Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment … Ended

2023-503254-12-00 Metastatic Prostate Cancer 5 2019-03-06
Phase 1 Study of AZD9833 Alone or in Combination in Women with Advanced Breast Cancer Ended

2023-506890-37-00 "Estrogen Receptor Positive HER2 Negative Advanced Brea 1 2019-03-01
Treatment for previously untreated patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) with an IDH1 or IDH2 mutatio… Ended

2022-502832-37-00 Acute myeloid leukemia 5 2019-03-01
A study to test IMGN632 in adults with CD123-positive Acute Myeloid Leukemia and other CD123 positive Hematologic cancers. Ended

2024-514195-40-00 Acute Myeloid Leukemia and other blood cancers 7 2019-02-28